Asarina Pharma

About:

Asarina Pharma is a company targeted on developing products to treat women with severe symptoms associated with the menstrual cycle.

Website: http://www.asarinapharma.com/

Top Investors: Idinvest Partners, Kurma Partners, Rosetta Capital, Karolinska

Description:

Asarina Pharma AB is a Swedish biotech company focusing on the development of Sepranolone (UC1010) for the treatment of premenstrual dysphoric disorder and other menstrually related conditions. The company's primary goal is to offer a novel therapy that is specifically designed for PMDD. Asarina has a second generation oral compound in preclinical development for PMDD